Biotechnology
Zantrene® kills melanoma cancer cells that overproduce FTO
* Zantrene® at low concentrations kills high FTO producing melanoma cancer cells * Sensitivity to Zantrene® correlates with FTO levels, where high FTO producing cells show up to 60x greater sensitivity than low FTO producing cells * Results are highly supportive of future clinical trials in ...
2021-09-30 11:58
11162
Recbio and Rhegen Signed an mRNA Vaccine Cooperation Agreement
TAIZHOU, China, Sept. 29, 2021 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (referred to as "Recbio") and Shenzhen Rhegen Biotechnology Co., Ltd. (referred to as "Rhegen Bio") recently signed a joint venture agreement to establish a joint venture company "Wuhan Rhecogen Biotechnology Co., ...
2021-09-29 19:37
3967
Hong Kong's first biotech firm to cultivate microalgae for its abundant plant-based protein for consumer application
HONG KONG, Sept. 29, 2021 /PRNewswire/ -- The bioscience start-up, Geb Impact Technology Company Limited has developed an advanced technology to rapidly cultivate clear water single-celled microalgae. Microalgae are the abundant and sustainable source of high-quality plant-based protein, fit for ...
2021-09-29 18:26
3436
Reversing Asia Pacific's biodiversity and nature loss crisis could result in US$4.3 trillion worth of nature-positive business opportunities
* A new study by AlphaBeta, Temasek and the World Economic Forum estimates that 63 percent ofAsia Pacific's GDP, US$19.5 trillion, is threatened by biodiversity and nature loss * It also identifies 59 nature-positive business opportunities that can unlock US$4.3 trillion in business value and ...
2021-09-29 15:36
4766
Molecular Stethoscope, Inc. Announces Presentation at 16th Annual Sequencing to Function: Analysis and Applications for the Future Meeting
Presentation highlights a path forward to lead the development of the Company's clinical-grade Next-Generation cf-mRNA Liquid Biopsy-Artificial Intelligence Technology Platform PALO ALTO, Calif., Sept. 29, 2021 /PRNewswire/ -- Molecular Stethoscope, Inc., a Precision Medicine biotechnology compa...
2021-09-29 15:00
2573
Innovent Releases Preliminary Results of the Phase Ia Dose-Escalation study of IBI315 (Anti-Her2/PD-1 Bispecific Antibody) in Patients with Advanced Solid Tumors at CSCO Annual Meeting 2021
SAN FRANCISCO and SUZHOU, China, Sept. 29, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...
2021-09-29 08:00
4244
Lifebit raises $60m to make vital biomedical data securely accessible for life changing research worldwide
LONDON, Sept. 29, 2021 /PRNewswire/ -- Lifebit Biotech Ltd – the leading precision medicine software company democratising access to biomedical data for governments, healthcare providers and research teams worldwide – has raised a $60 million Series B funding round, led by global investment firm T...
2021-09-29 08:00
5972
MetaCell launches innovative Cloud Hosting for life science and healthcare
CAMBRIDGE, Mass., Sept. 29, 2021 /PRNewswire/ -- MetaCell, an innovative life
science software company specialized in creating cutting-edge research software
for major pharma, biotech, and academic institutions, has launchedMetaCell
Cloud Hosting
2021-09-29 07:54
2684
BioVaxys Begins Toxicity Study Ahead of CoviDTH IND Submission
VANCOUVER, BC, Sept. 28, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)("BioVaxys" or "Company"), announced today that it has started its plannedin vivo animal toxicology study of CoviDTH in parallel with the preparation of an IND submission. Under the terms ...
2021-09-28 20:00
7442
Zymo Research Pays it Forward With Their Commitment to Eradicate the COVID-19 Pandemic in India
DNA/RNA Shield – DirectDetect™ reagent eliminates RNA extraction for rapid deployment of COVID-19 tests in affected countries IRVINE, Calif., Sept. 28, 2021 /PRNewswire/ -- Zymo Research has donated one million COVID-19 test kits that include its newDNA/RNA Shield - DirectDetect™ reagent and col...
2021-09-28 14:57
3330
Insectmeal outcompetes fishmeal in shrimp diets
SINGAPORE, Sept. 28, 2021 /PRNewswire/ -- Singapore headquartered, Nutrition Technologies, recently announced the results of their recent trial using the alternative protein, Black Soldier Fly Meal ("BSF meal"), to replace fishmeal in shrimp diets. The trial found that shrimp fed with diets using...
2021-09-28 12:27
3566
Innovent and UNION Therapeutics Enter into Strategic Collaboration and License Agreement for Orismilast, a Next-generation PDE4 Inhibitor for Inflammatory Dermatology Conditions
SAN FRANCISCO and SUZHOU, China and HELLERUP, Denmark, Sept. 28, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmun...
2021-09-28 08:00
4456
Foresees the Future Trend of Laboratory Technology
BEIJING, Sept. 27, 2021 /PRNewswire/ -- On September 27, 2021, NIKYANG made a stunning appearance at the 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) with its latest innovative laboratory automation solutions that are essentially used for the drug R&D analysis and ...
2021-09-27 21:03
1974
JW Therapeutics Announces IND Approval for the Clinical Trial of JWCAR129
SHANGHAI, Sept. 27, 2021 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, today announced that it has received the Investigational New Drug (IND) clearance from the National Medi...
2021-09-27 20:00
4627
Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC
* Seegene unveils its first fully automated MDx system, STARlet-AIOS: All-in-One System at the 2021 AACC held in theAtlanta, GA, United States * AIOS is the MDx system that integrates Seegene's liquid handler and real-time PCR instruments. * Seegene MDx system will efficiently access a wide ...
2021-09-27 19:02
3268
GenScript ProBio Congratulates EyeGene for Clinical Trial Approval for mRNA COVID-19 Vaccine in South Korea
NANJING, China, Sept. 27, 2021 /PRNewswire/ -- EyeGene's mRNA vaccine against COVID-19, namely "EG-COVID", has recently been approved for clinical trials by South Korea's Ministry of Food and Drug Safety (MFDS). GenScript ProBio hereby extended its warm congratulations to the partner. EG-COVID ...
2021-09-27 18:35
3123
Lipidor announces approval to start Phase III clinical study of drug candidate AKP02 for treatment of psoriasis
STOCKHOLM, Sept. 27, 2021 /PRNewswire/ -- Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announced today that the company's Phase III clinical study of its drug candidate AKP02 for the treatment of psoriasis has been approved by the Indian Medical Products Agency and is ready to start...
2021-09-27 17:37
1984
"Hong Kong Heritage Pork" brings high-quality local pork to Hong Kong through an innovative double testing method
HONG KONG, Sept. 27, 2021 /PRNewswire/ -- John Lau Hon Kit, the founder of Hong Kong Heritage Pork, worked to introduce into his own pig farm a self-breeding and self-raising, and self-sale technique that allows everyone inHong Kong to taste fresh, delicious, and safe locally raised pork.John Lau...
2021-09-27 17:30
2201
Innovent and AnHeart Announce Interim Data from Phase 2 Trial of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting
SAN FRANCISCO and SUZHOU, China, Sept. 27, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...
2021-09-27 08:00
4442
JW Therapeutics Announces Updated 1-year Follow-up Result of Relmacabtagene Autoleucel Injection At the 24th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO)
SHANGHAI, Sept. 26, 2021 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, today announced updated 1-year follow-up result of relmacabtagene autoleucel injection (relma-cel) for t...
2021-09-26 20:00
5192
Week's Top Stories
Most Reposted
DayOne Secures Over 1GW Renewable Energy in Malaysia in Landmark TNB Partnership
[Picked up by 297 media titles]
2026-06-04 23:55
DayOne Appoints Nicolas Aguzin to Board of Directors, Strengthening Global Governance and Capital Markets Expertise
[Picked up by 281 media titles]
2026-05-29 15:50Pudu Robotics and Shenzhen CTID Co. Ltd Launch the World's First Full-Scenario Robot-Serviced Hotel Project
[Picked up by 275 media titles]
2026-06-01 18:00Creality 3D Successfully Listed in Hong Kong
[Picked up by 271 media titles]
2026-05-29 11:21
Creality Charts Next Decade as AI-Powered Consumer 3D Creative Platform, Hong Kong listing anchors the company's full-stack ecosystem shift
[Picked up by 269 media titles]
2026-05-30 11:58
Most Read
Creality Charts Next Decade as AI-Powered Consumer 3D Creative Platform, Hong Kong listing anchors the company's full-stack ecosystem shift
2026-05-30 11:58
8232
AMTD's Successful Completion of Acquisition of The Ritz-Carlton, Perth, Valued at A$280 Million
2026-05-29 21:50
7623
Creality 3D Successfully Listed in Hong Kong
2026-05-29 11:21
7180
Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering
2026-05-29 22:00
6740